Review of a pharmacist discharge medication reconciliation program: characterization of medication discrepancies and prescriber follow up in patients with.

Slides:



Advertisements
Similar presentations
© Institute for Safe Medication Practices Canada 2008® Medication Reconciliation in Long Term Care Atlantic Node Collaborative Margaret Colquhoun SHN Intervention.
Advertisements

Advanced Illness Management Sutter Health Lois Cross RN BSN ACM Sutter Health
Connie N. Hess, MD, Bimal R. Shah, MD, MBA, S. Andrew Peng, MS, Laine Thomas, PhD, Matthew T. Roe, MD, MHS, Eric D. Peterson, MD, MPH Relationship of Early.
Context and Overview of Recommended Actions to Reduce Psychiatric Readmissions Michael Trangle, MD Associate Medical Director, Behavioral Health Division.
Alachua County Initiative to Reduce Avoidable Hospital Utilization Cathy Cook LCSW, Shands Diane Dimperio, Alachua County Health Department October 12,
Transitions of Care: From Hospital to SNF Steven Tam, MD Assistant Clinical Professor UCI Program in Geriatrics, Internal Medicine.
Disease State Management The Pharmacist’s Role
Camden Coalition of Healthcare Providers
Applying Transition Management Tools to Care for Chronic Patients Vera Dvorak, MD Julie Garcia, MSW, ACM, LNHA Inova January 28-29, 2013 Integrated Transitional.
Readmissions Experience Hunterdon Medical Center CMO Roundtable October 2014.
2.11 Conduct Medication Management University Medical Center Health System Lubbock, TX Jason Mills, PharmD, RPh Assistant Director of Pharmacy.
HFMA December Attacking Rising Costs 23% of the Medicare population has a chronic condition with 5 or more co-morbid conditions that compel them.
5/24/20151 Fitting the Pieces Together Utilizing a Hospitalist in the ED to Reduce Admissions Presented by: Patty Williamson, CFO Isidoros Vardaros, M.D.
Improving care transitions at Harborview Medical Center Frederick M. Chen, MD, MPH Chief of Family Medicine Associate Professor, University of Washington.
Risk Assessment - What are we Learning? Stephanie Mudd RN MSM CCM Supervisor, Care Management TG/AH/MBCH 1 Presented by Washington State Hospital Association.
Medication Reconciliation Insert your hospital’s name here.
Barriers to Care Transitions Each health plan has different forms and different requirements for authorizations Multiple health plan formularies Providers.
As noted by Gary H. Lyman (JCO, 2012) “CER is an important framework for systematically identifying and summarizing the totality of evidence on the effectiveness,
Evaluation of lipid and glucose monitoring after implementation of a pharmacist initiated antipsychotic monitoring form. Erin McCleeary Monthei, Pharm.D.
The Pharmacist’s Role in Transition of Care
Care Coordination What is it? How Do We Get Started?
Medicare Patients Rights and Better Care Transitions Michael Burgess New York StateWide Senior Action Council, September 13, 2012.
Overview Community Care of North Carolina. Our Vision and Key Principles  Develop a better healthcare system for NC starting with public payers  Strong.
Care Transitions (CT) Special Innovation Project (SIP) THIS MATERIAL WAS PREPARED BY THE ARKANSAS FOUNDATION FOR MEDICAL CARE INC. (AFMC), THE MEDICARE.
Quality Improvement HIT Design to Support Teamwork and Communication Lecture a This material (Comp12_Unit7a) was developed by Johns Hopkins University,
1 Leveraging the Culture of Performance Excellence in Ontario’s Health System HSPRN is an inter-organization Network funded by the Ontario Ministry of.
HRET/K-HEN Readmissions Race Office Hour Building a Multidisciplinary Care Transitions Team January 25, 2013.
Hospitalizations and the Patient Discharge: Has Society Overlooked Quality in Favor of Efficiency? (and what if anything can we, as individuals do about.
IMPACT: Improving Care Transitions Risk Stratification Tool Elya Moore, PhD Deputy Director Whatcom Alliance for Health Advancement Presented at Washington.
Reduction Of Hospital Readmissions Hany Salama, MD Diplomat ABIM IM Hospice and Palliative Care Sleep Medicine.
North Carolina’s 646 Quality Demonstration National Academy for State Health Policy’s 23 rd Annual State Health Policy Conference Denise Levis Hewson,
Medication Reconciliation: The Inpatient Hospitalist Perspective
Are hospital readmissions in the elderly preventable? Antonio Sarría-Santamera MD PhD Institute of Health Carlos III University of Alcalá DUKE-NUS HSSR.
Interdisciplinary Teamwork in a Transitional Primary Care Clinic Tamara Malm, PharmD, MPH, BCPS September 18, 2015.
Reducing Re-hospitalizations: The ICU Survivors Follow-Up Care Program Shirley F. Jones, MD Scott & White Healthcare/Texas A&M Health Science Center.
Corticosteroid dosing in the treatment of acute exacerbations of COPD Kurt A. Wargo, Pharm.D., BCPS, Takova D. Wallace, Pharm.D. Candidate 2014, Ryan E.
Unit 5a: Care Coordination HIT Design for Teamwork and Communication This material was developed by Johns Hopkins University, funded by the Department.
Introduction The Readmission and Transition of Care teams at Scott & White Hospital – Brenham combined in an effort to develop, in the absence of a Case.
ALI R. RAHIMI, BOBBY WRIGHTS, MD, HOSSEIN AKHONDI, MD & CHRISTIAN M. RICHARD, MSC Clinical Correlation Between Effective Anticoagulants & Risk of Stroke:
Polypharmacy May 2008 CRIT Heidi Auerbach, MD Copyright Boston University Medical Center.
Pharmacist’s Role in Transitions of Care
The Affordable Care Act is Transforming Health Care in our Community: The Washington Heights-Inwood Regional Health Collaborative 18th Annual NHMA Conference.
The National Hospital Care Survey Linda McCaig, M.P.H. National Center for Health Statistics August 8, 2012.
MAKING CARING CONNECTIONS CONTINUITY OF CARE TRANSFER PROJECT Staff Education Presentation Hospital Presenter’s Name Date.
HIT FINAL EXAM REVIEW HI120.
Medication Reconciliation: Opportunity to Improve Patient Safety Presented to [Insert Group or Committee Name of Front-line Staff] [Date] By [Insert Name]
From Knowledge to Practice Translation A Multidisciplinary Intervention to Reduce 30 day Heart Failure Readmissions.
Using a Novel Two-Pronged Pharmacy Model in a High-Risk Care Management Program to Address Medication Reconciliation and Access Kakoza RM 1, 2, De Leon.
Pam Coleman Reducing Avoidable Re- Hospitalizations and Improving Care Transitions National Academy for State Health Policy October 4, 2011 Pam Coleman.
Quality Improvement and Care Transitions in a Medical Home Maryland Learning Collaborative May 21, 2014 Stephanie Garrity, M.S., Cecil County Health Officer.
Partnership for Patients
Medication Reconciliation: Spread to MSNU & 4 West Pre- Admit Clinic.
Best Practices in Readmissions Susie Payne, RN MSHA Director Resource Management Clearview Regional Medical Center.
Printed by A Follow-Up Study of Patterns of Service Use and Cost of Care for Discharged State Hospital Clients in Community-Based.
Improving Transitions of Care from Hospital to Home: A Health Care Reform Priority Gina Gill Glass, MD, FAAFP Barbara J. Roehl, MD, MBA, CAQ Geriatrics.
Spotlight Case Postdischarge Follow-Up Phone Call.
Presenters: Kathy Cummings, ICSI Kattie Bear-Pfaffendorf, MHA Janelle Shearer, Stratis Health.
The View Through Different Lenses. There are no relevant financial relationships to disclose or conflicts of interest to resolve.
Pharmacy Health Information Technology Collaborative Presenter: Shelly Spiro RPh, FASCP Pharmacy HIT Collaborative, Executive Director.
Comparison of pharmacy technician versus nurse obtained medication histories in the emergency department Marija Markovic, Pharm.D. PGY-1 Pharmacy Practice.
Malnutrition is common in US hospitalized patients In 2010, approximately 1.2 million hospitalized patients over the age of 18 had.
 Proposed Rule by the Centers for Medicare & Medicaid Services on 11/03/2015Centers for Medicare & Medicaid Services11/03/2015  Revises the discharge.
From Hospital to Home: Medical Students Observe Patients in Transition Martha S. Terry, MD Assistant Professor of Clinical Family and Community Medicine.
Timing of Post-discharge Venous Thromboembolic Events and Effect of Pharmacologic Prophylaxis in Hospitalized Patients Paul J. Grant MD, Todd Greene PhD,
Spotlight Case December 2004 Discharge Fumbles. 2 Source and Credits This presentation is based on the Dec AHRQ WebM&M Spotlight Case in Hospital.
Care Transitions for Medication Safety in the Community
Courtney selby, Pharm.d. arcare pgy1 Community pharmacy resident
Review of a pharmacist discharge medication reconciliation program: characterization of medication discrepancies and prescriber follow up in patients with.
Mission Health System COPD Readmission Data
Chronic Disease Transitional Care Northridge Hospital Medical Center
Presentation transcript:

Review of a pharmacist discharge medication reconciliation program: characterization of medication discrepancies and prescriber follow up in patients with and without recent hospital admission Brittany Reynolds, PharmD Candidate, Trista Pfeiffenberger PharmD, Monique Alford, PharmD BACKGROUND The authors of this presentation have the following disclosures concerning possible financial or personal relationships with commercial entities: Brittany Reynolds, Pharm D Candidate: No disclosures. Trista Pfeiffenberger, PharmD: No disclosures. Monique Alford, PharmD: No disclosures Pharmacists have an opportunity at the time of discharge to monitor for medication discrepancies and prevent adverse drug events. The Transitional Care program aims to prevent adverse drug events and improve continuity of care for patients after hospital discharge. Community Care of North Carolina (CCNC) is a group of nurse case managers and pharmacists who work with primary care providers (PCPs) as part of patient centered medical homes. AccessCare is a network of CCNC which covers 24 of North Carolina’s 100 counties. One component of AccessCare’s Transitional Care program involves a pharmacist conducting reconciliation and clinical review of medications on eligible hospitalized patients both during the hospital stay and at the time of discharge. OBJECTIVES RISK FACTORS FOR READMISSION REFEFENCES DATA COLLECTION FORM Inclusion: Medicaid or dually eligible Medicare/Medicaid patients who received inpatient and discharge reconciliation services by an AccessCare pharmacist on or after July 1, Exclusion: Patients who are discharged to a facility in which medications are managed and administered by staff (sub-acute or long term care). The study population will include 50 patients with a first admission to the hospital and 50 patients with a readmission to the hospital, both within the most recent 6 month period. Design: Retrospective, observational study Methods: Data will be collected from the following sources NC Medicaid claims information CCNC case management information system CCNC medication reconciliation documentation form Documentation of communication between AccessCare pharmacist and hospitalist or PCP. Analysis: Descriptive statistics will be used to compare the characteristics of patients with their first admission against patients with a previous admission in a six month period. METHODS PATIENT DEMOGRAPHICS Patient Identifier:Age: Patient’s first admission within last 6 mos?  Yes  NoLength of Stay: _______ days Aged, Blind, Disabled status?  Yes  NoDual eligible?  Yes  No Case Management Status:  Medium  Heavy  Deferred  Pending Primary Discharge Diagnosis From Current Admission: _________________________ Co-morbid Conditions:  ADHD/ADD  Anxiety  Asthma  Bipolar  Blood/Blood forming organs  Cancer  Cerebrovascular/CVA  CHF  Chronic Pain  CKD  COPD  CVD  Depression  Diabetes  Endocrine/Metabolic  Genital/Urinary  GI  HTN/CVD  ID/Parasitic Dx  Liver  Muscular/Skeletal  Nervous System  Psychosis  PTSD  Respiratory  Schizophrenia  Skin Diseases Previous admissions in last 6 months: Date:__________________ Primary Discharge Diagnosis:____________________________ Total Number of Medications: ________________________ MEDICATION DISCREPANCIES Discrepant Drug Name High Risk Medication? Discrepancy Type (#) UrgencyTiming  Yes  No  Urgent  Non-urgent  Pre-hospital  During/Post-hospital  Unknown  Yes  No  Urgent  Non-urgent  Pre-hospital  During/Post-hospital  Unknown  Yes  No  Urgent  Non-urgent  Pre-hospital  During/Post-hospital  Unknown PROVIDER RECOMMENDATIONS AND FOLLOW UP Recommendation(s) sent to:  Hospitalist  PCP Follow-up from PCP:  Received; accepted ____/_____ recommendations  No follow-up documented Follow-up from Hospitalist:  Received; accepted ____/_____ recommendations  No follow-up documented DISCREPANCY IDENTIFICATION KEY 1.Discontinued medication per discharge instructions, but still taking 2.Not taking prescribed discharge medications 3.Poor adherence to chronic medication (pre-hospital visit) 4.Medications dose/frequency/duration 5.Potential transcription error, combo drug, misnaming 6. Absolute contraindication (Drug-drug, drug-dz, drug-food) 7. Interaction non-absolute (Drug-drug, drug- dz, drug-food) 8. Adverse event/side effect reported 9. Drug allergy 10. Therapeutic duplication 11. Unconfirmed discontinuation 12. Unreported medications DISCLOSURES 1.Forster AJ, Clark HD, et al. Adverse events among medical patients after discharge from hospital. CMAJ 2004;170(3): Forster AJ, Murff HJ, et al. The incidence and severity of adverse events affecting patients after discharge from the hospital. Ann Intern Med 2003;138(3): Kripalani S, LeFevre F, et al. Deficits in communication and information between hospital-based and primary care physicians: implications for patient safety and continuity of care. JAMA 2007;297(8): Compare medication discrepancies identified and prescriber follow up received in patients admitted for the first time versus readmitted patients, both of whom receive discharge medication reconciliation services by a hospital based pharmacist. Compare medication discrepancies by high risk status of the drug, discrepancy type, and urgency. Contrast first time admissions against readmissions for discharge diagnosis, total number of medications, comorbid conditions, and other demographic variables. Readmission Early Hospital Discharge 2 Therapeutic Error 1,2 Adverse Drug Effects 1,2 Inadequate Follow Up 3 Disease Progression